Biomedical Distribution Colombia S L Ltda, commonly referred to as BDC, is a leading player in the biomedical distribution sector, headquartered in Colombia. Established in 2010, the company has rapidly expanded its operations across major regions, including Bogotá and Medellín, solidifying its presence in the healthcare supply chain. Specialising in the distribution of medical devices, laboratory equipment, and pharmaceutical products, BDC is recognised for its commitment to quality and innovation. The company prides itself on offering unique solutions tailored to the needs of healthcare professionals, ensuring that they have access to the latest technologies and products. With a strong market position, BDC has achieved notable milestones, including partnerships with renowned manufacturers and a reputation for reliability in service delivery. As a trusted distributor, Biomedical Distribution Colombia S L Ltda continues to play a vital role in enhancing healthcare outcomes across the nation.
How does Biomedical Distribution Colombia S L Ltda's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Transport Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biomedical Distribution Colombia S L Ltda's score of 69 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biomedical Distribution Colombia S L Ltda, headquartered in Colombia, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of United Parcel Service, Inc. (UPS), and therefore, it may inherit emissions data and climate commitments from its parent organisation. As a subsidiary, Biomedical Distribution Colombia S L Ltda's climate initiatives and performance may be influenced by UPS's sustainability strategies. UPS has established various climate commitments, including participation in the Carbon Disclosure Project (CDP) and other industry-standard initiatives aimed at reducing carbon footprints. However, specific reduction targets or achievements for Biomedical Distribution Colombia S L Ltda are not available. The absence of direct emissions data suggests that the company may still be in the process of developing its own climate strategy or reporting framework. As the global focus on climate action intensifies, it is likely that Biomedical Distribution Colombia S L Ltda will align its practices with the broader commitments of its parent company, UPS, to enhance its sustainability profile in the future.
Access structured emissions data, company-specific emission factors, and source documents
2009 | 2010 | 2011 | 2012 | 2014 | 2015 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 11,437,000,000 | 00,000,000,000 | 00,000,000,000 | - | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Scope 2 | 924,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 6,373,000,000 | - | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biomedical Distribution Colombia S L Ltda is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.